Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Bepler

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Contemporary Clinical Trials|March 9, 2011
Proactive recruitment of cancer patients' social networks into a smoking cessation trialLori A Bastian, Laura J Fish, Bercedis L Peterson, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevanceGerold Bepler, Zhong Zheng, Ashish Gautam, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 16, 2010
Lung cancer patients' decisions about clinical trials and the theory of planned behaviorGwendolyn P Quinn, Christie L Pratt, Kathy Bryant-George, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancerGerold Bepler, K Eric Sommers, Alan Cantor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer PatientsChristine M Lusk, Donovan Watza, Greg Dyson, et al.
American Journal of Health Promotion : AJHP|January 5, 2013
Assessment of the impact of adjunctive proactive telephone counseling to promote smoking cessation among lung cancer patients' social networksLori A Bastian, Laura J Fish, Bercedis L Peterson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2013
Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinomaBen C Creelan, Scott Antonia, David Noyes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2011
Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancerGerold Bepler, Thomas J Dilling, Henry Wagner, et al.
Cancer|February 27, 2008
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or olderGeorge R Simon, Martine Extermann, Alberto Chiappori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancerIbrahim S Aljada, Nithya Ramnath, Kathleen Donohue, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Contemporary Clinical Trials|March 9, 2011
Proactive recruitment of cancer patients' social networks into a smoking cessation trialLori A Bastian, Laura J Fish, Bercedis L Peterson, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevanceGerold Bepler, Zhong Zheng, Ashish Gautam, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 16, 2010
Lung cancer patients' decisions about clinical trials and the theory of planned behaviorGwendolyn P Quinn, Christie L Pratt, Kathy Bryant-George, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancerGerold Bepler, K Eric Sommers, Alan Cantor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer PatientsChristine M Lusk, Donovan Watza, Greg Dyson, et al.
American Journal of Health Promotion : AJHP|January 5, 2013
Assessment of the impact of adjunctive proactive telephone counseling to promote smoking cessation among lung cancer patients' social networksLori A Bastian, Laura J Fish, Bercedis L Peterson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2013
Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinomaBen C Creelan, Scott Antonia, David Noyes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2011
Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancerGerold Bepler, Thomas J Dilling, Henry Wagner, et al.
Cancer|February 27, 2008
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or olderGeorge R Simon, Martine Extermann, Alberto Chiappori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancerIbrahim S Aljada, Nithya Ramnath, Kathleen Donohue, et al.
Pageof 16